Correlation Between Exelixis and OncoVista Innovative
Can any of the company-specific risk be diversified away by investing in both Exelixis and OncoVista Innovative at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Exelixis and OncoVista Innovative into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Exelixis and OncoVista Innovative Therapies, you can compare the effects of market volatilities on Exelixis and OncoVista Innovative and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Exelixis with a short position of OncoVista Innovative. Check out your portfolio center. Please also check ongoing floating volatility patterns of Exelixis and OncoVista Innovative.
Diversification Opportunities for Exelixis and OncoVista Innovative
0.14 | Correlation Coefficient |
Average diversification
The 3 months correlation between Exelixis and OncoVista is 0.14. Overlapping area represents the amount of risk that can be diversified away by holding Exelixis and OncoVista Innovative Therapies in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on OncoVista Innovative and Exelixis is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Exelixis are associated (or correlated) with OncoVista Innovative. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of OncoVista Innovative has no effect on the direction of Exelixis i.e., Exelixis and OncoVista Innovative go up and down completely randomly.
Pair Corralation between Exelixis and OncoVista Innovative
Given the investment horizon of 90 days Exelixis is expected to under-perform the OncoVista Innovative. But the stock apears to be less risky and, when comparing its historical volatility, Exelixis is 16.56 times less risky than OncoVista Innovative. The stock trades about -0.09 of its potential returns per unit of risk. The OncoVista Innovative Therapies is currently generating about 0.21 of returns per unit of risk over similar time horizon. If you would invest 0.01 in OncoVista Innovative Therapies on September 12, 2024 and sell it today you would earn a total of 0.01 from holding OncoVista Innovative Therapies or generate 100.0% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Exelixis vs. OncoVista Innovative Therapies
Performance |
| Timeline |
| Exelixis |
| OncoVista Innovative |
Exelixis and OncoVista Innovative Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Exelixis and OncoVista Innovative
The main advantage of trading using opposite Exelixis and OncoVista Innovative positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Exelixis position performs unexpectedly, OncoVista Innovative can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in OncoVista Innovative will offset losses from the drop in OncoVista Innovative's long position.| Exelixis vs. CytomX Therapeutics | Exelixis vs. Instil Bio | Exelixis vs. Spero Therapeutics | Exelixis vs. Assembly Biosciences |
| OncoVista Innovative vs. Grey Cloak Tech | OncoVista Innovative vs. CuraScientific Corp | OncoVista Innovative vs. Love Hemp Group | OncoVista Innovative vs. Greater Cannabis |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the USA ETFs module to find actively traded Exchange Traded Funds (ETF) in USA.
Other Complementary Tools
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Bonds Directory Find actively traded corporate debentures issued by US companies |